<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>dna Archivi - InfoNurse</title>
	<atom:link href="https://infonurse.it/tag/dna/feed" rel="self" type="application/rss+xml" />
	<link>https://infonurse.it/tag/dna</link>
	<description>Quotidiano Infermieri</description>
	<lastBuildDate>Wed, 05 May 2021 21:44:35 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://infonurse.it/wp-content/uploads/2017/10/cropped-info-NURSE-verticale-32x32.png</url>
	<title>dna Archivi - InfoNurse</title>
	<link>https://infonurse.it/tag/dna</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Mirri (Asl Rm1): &#8220;Grazie a studio Dna ora farmaci target contro tumori&#8221;</title>
		<link>https://infonurse.it/mirri-asl-rm1-grazie-a-studio-dna-ora-farmaci-target-contro-tumori/33558</link>
					<comments>https://infonurse.it/mirri-asl-rm1-grazie-a-studio-dna-ora-farmaci-target-contro-tumori/33558#respond</comments>
		
		<dc:creator><![CDATA[Redazione InfoNurse]]></dc:creator>
		<pubDate>Wed, 05 May 2021 21:44:34 +0000</pubDate>
				<category><![CDATA[Calabria]]></category>
		<category><![CDATA[Comunicati]]></category>
		<category><![CDATA[Lazio]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Regionali]]></category>
		<category><![CDATA[Asl]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[mirri]]></category>
		<category><![CDATA[rm1]]></category>
		<guid isPermaLink="false">https://infonurse.it/?p=33558</guid>

					<description><![CDATA[<p>InfoNurse -</p>
<p>La gestione del paziente oncologico in equipe, secondo un percorso guidato che va dalla diagnosi al trattamento, restituisce vantaggi innegabili.</p>
<p>L'articolo <a href="https://infonurse.it/mirri-asl-rm1-grazie-a-studio-dna-ora-farmaci-target-contro-tumori/33558">Mirri (Asl Rm1): &#8220;Grazie a studio Dna ora farmaci target contro tumori&#8221;</a> proviene da <a href="https://infonurse.it">InfoNurse</a>.</p>
]]></description>
		
					<wfw:commentRss>https://infonurse.it/mirri-asl-rm1-grazie-a-studio-dna-ora-farmaci-target-contro-tumori/33558/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
